JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by Academy of Managed Care Pharmacy in Journal of Managed Care & Specialty Pharmacy
- Vol. 28 (1) , 108-114
Abstract
DISCLOSURES: Funding for this summary was contributed by Arnold Ventures, The Donaghue Foundation, Harvard Pilgrim Health Care, and Kaiser Foundation Health Plan to the Institute for Clinical and E...Keywords
This publication has 32 references indexed in Scilit:
- Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbiditiesAllergy, 2015
- Sleep Disturbances in Adults with Eczema Are Associated with Impaired Overall Health: A US Population-Based StudyJournal of Investigative Dermatology, 2015
- Guidelines of care for the management of atopic dermatitisJournal of the American Academy of Dermatology, 2014
- Guidelines of care for the management of atopic dermatitisJournal of the American Academy of Dermatology, 2014
- Associations of Childhood Eczema Severity: A US Population-Based StudyDermatitis®, 2014
- Adult eczema prevalence and associations with asthma and other health and demographic factors: A US population–based studyJournal of Allergy and Clinical Immunology, 2013
- Eczema severity in preadolescent children and its relation to sex, filaggrin mutations, asthma, rhinitis, aggravating factors and topical treatment: a report from the BAMSE birth cohortBritish Journal of Dermatology, 2013
- Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's HealthJournal of Investigative Dermatology, 2011
- What are the best outcome measurements for atopic eczema? A systematic reviewJournal of Allergy and Clinical Immunology, 2007
- The burden of skin diseases: 2004Journal of the American Academy of Dermatology, 2006